【Generfull Biotech Co., Ltd.】Q1 2026 EPS -0.50 NTD
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Generfull Biotech Co., Ltd. announced its Q1 2026 financial results, with basic EPS of -0.50 NTD, operating revenue of 0.03 billion NTD, and net loss after tax of -0.76 billion NTD.